IL‐7 is superior to IL‐2 for ex vivo expansion of tumour‐specific CD4+ T cells
S Caserta, P Alessi, V Basso… - European journal of …, 2010 - Wiley Online Library
It is well established that tumours hinder both natural and vaccine‐induced tumour‐specific
CD4+ T‐cell responses. Adoptive T‐cell therapy has the potential to circumvent functional …
CD4+ T‐cell responses. Adoptive T‐cell therapy has the potential to circumvent functional …
[PDF][PDF] IL-7 is superior to IL-2 for ex vivo expansion of tumour-specific CD4+ T cells
S Caserta, P Alessi, V Basso, A Mondino - Eur. J. Immunol, 2010 - academia.edu
It is well established that tumours hinder both natural and vaccine-induced tumourspecific
CD4+ T-cell responses. Adoptive T-cell therapy has the potential to circumvent functional …
CD4+ T-cell responses. Adoptive T-cell therapy has the potential to circumvent functional …
IL‐7 is superior to IL‐2 for ex vivo expansion of tumour‐specific CD4+ T cells
S Caserta, P Alessi, V Basso, A Mondino - European Journal of …, 2010 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: p> It is well established that tumours hinder both
natural and vaccine‐induced tumour‐specific CD4< jats: sup>+</jats: sup> T‐cell …
natural and vaccine‐induced tumour‐specific CD4< jats: sup>+</jats: sup> T‐cell …
IL‐7 is superior to IL‐2 for ex vivo expansion of tumour‐specific CD4+ T cells
S Caserta, P Alessi, V Basso, A Mondino - European Journal of …, 2010 - infona.pl
It is well established that tumours hinder both natural and vaccine‐induced tumour‐specific
CD4+ T‐cell responses. Adoptive T‐cell therapy has the potential to circumvent functional …
CD4+ T‐cell responses. Adoptive T‐cell therapy has the potential to circumvent functional …
IL-7 is superior to IL-2 for ex vivo expansion of tumour-specific CD4 (+) T cells
S Caserta, P Alessi, V Basso, A Mondino - sussex.figshare.com
It is well established that tumours hinder both natural and vaccine-induced tumour-specific
CD4 (+) T-cell responses. Adoptive T-cell therapy has the potential to circumvent functional …
CD4 (+) T-cell responses. Adoptive T-cell therapy has the potential to circumvent functional …
IL-7 is superior to IL-2 for ex vivo expansion of tumour-specific CD4 (+) T cells.
S Caserta, P Alessi, V Basso… - European Journal of …, 2010 - europepmc.org
It is well established that tumours hinder both natural and vaccine-induced tumour-specific
CD4 (+) T-cell responses. Adoptive T-cell therapy has the potential to circumvent functional …
CD4 (+) T-cell responses. Adoptive T-cell therapy has the potential to circumvent functional …
IL-7 is superior to IL-2 for ex vivo expansion of tumour-specific CD4 (+) T cells
S Caserta, P Alessi, V Basso… - European journal of …, 2010 - pubmed.ncbi.nlm.nih.gov
It is well established that tumours hinder both natural and vaccine-induced tumour-specific
CD4 (+) T-cell responses. Adoptive T-cell therapy has the potential to circumvent functional …
CD4 (+) T-cell responses. Adoptive T-cell therapy has the potential to circumvent functional …